Global Adalimumab Biosimilars Supply, Demand and Key Producers, 2023-2029
The global Adalimumab Biosimilars market size is expected to reach $ 31050 million by 2029, rising at a market growth of 3.8% CAGR during the forecast period (2023-2029).
Adalimumab, as a fully human anti-tumor necrosis factor alpha (TNF-?) monoclonal antibody, can specifically bind to soluble human TNF-? and block its interaction with cell surface TNF receptors p55 and p75. Thereby effectively blocking the inflammatory effect of TNF-?.
This report studies the global Adalimumab Biosimilars production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Adalimumab Biosimilars, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Adalimumab Biosimilars that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Adalimumab Biosimilars total production and demand, 2018-2029, (K Units)
Global Adalimumab Biosimilars total production value, 2018-2029, (USD Million)
Global Adalimumab Biosimilars production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Adalimumab Biosimilars consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Adalimumab Biosimilars domestic production, consumption, key domestic manufacturers and share
Global Adalimumab Biosimilars production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Adalimumab Biosimilars production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Adalimumab Biosimilars production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units).
This reports profiles key players in the global Adalimumab Biosimilars market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Biotech, Hisun Pharmaceutical, Innovent Biologics, Fuhong Hanlin, China Biopharmaceuticals, Chia Tai Tianqing Pharmaceutical Group, China Cell Engineering, Suzhou Zhonghe Biomedical Technology and Amgen, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Adalimumab Biosimilars market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Adalimumab Biosimilars Market, By Region:
1. How big is the global Adalimumab Biosimilars market?
2. What is the demand of the global Adalimumab Biosimilars market?
3. What is the year over year growth of the global Adalimumab Biosimilars market?
4. What is the production and production value of the global Adalimumab Biosimilars market?
5. Who are the key producers in the global Adalimumab Biosimilars market?
Adalimumab, as a fully human anti-tumor necrosis factor alpha (TNF-?) monoclonal antibody, can specifically bind to soluble human TNF-? and block its interaction with cell surface TNF receptors p55 and p75. Thereby effectively blocking the inflammatory effect of TNF-?.
This report studies the global Adalimumab Biosimilars production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Adalimumab Biosimilars, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Adalimumab Biosimilars that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Adalimumab Biosimilars total production and demand, 2018-2029, (K Units)
Global Adalimumab Biosimilars total production value, 2018-2029, (USD Million)
Global Adalimumab Biosimilars production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Adalimumab Biosimilars consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Adalimumab Biosimilars domestic production, consumption, key domestic manufacturers and share
Global Adalimumab Biosimilars production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Adalimumab Biosimilars production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Adalimumab Biosimilars production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units).
This reports profiles key players in the global Adalimumab Biosimilars market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Biotech, Hisun Pharmaceutical, Innovent Biologics, Fuhong Hanlin, China Biopharmaceuticals, Chia Tai Tianqing Pharmaceutical Group, China Cell Engineering, Suzhou Zhonghe Biomedical Technology and Amgen, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Adalimumab Biosimilars market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Adalimumab Biosimilars Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- 80mg
- 40mg
- 20mg
- Adult
- Child
- Biotech
- Hisun Pharmaceutical
- Innovent Biologics
- Fuhong Hanlin
- China Biopharmaceuticals
- Chia Tai Tianqing Pharmaceutical Group
- China Cell Engineering
- Suzhou Zhonghe Biomedical Technology
- Amgen
- Sandoz
- Boehringer Ingelheim
- Mylan
- Biogen
1. How big is the global Adalimumab Biosimilars market?
2. What is the demand of the global Adalimumab Biosimilars market?
3. What is the year over year growth of the global Adalimumab Biosimilars market?
4. What is the production and production value of the global Adalimumab Biosimilars market?
5. Who are the key producers in the global Adalimumab Biosimilars market?
1 SUPPLY SUMMARY
1.1 Adalimumab Biosimilars Introduction
1.2 World Adalimumab Biosimilars Supply & Forecast
1.2.1 World Adalimumab Biosimilars Production Value (2018 & 2022 & 2029)
1.2.2 World Adalimumab Biosimilars Production (2018-2029)
1.2.3 World Adalimumab Biosimilars Pricing Trends (2018-2029)
1.3 World Adalimumab Biosimilars Production by Region (Based on Production Site)
1.3.1 World Adalimumab Biosimilars Production Value by Region (2018-2029)
1.3.2 World Adalimumab Biosimilars Production by Region (2018-2029)
1.3.3 World Adalimumab Biosimilars Average Price by Region (2018-2029)
1.3.4 North America Adalimumab Biosimilars Production (2018-2029)
1.3.5 Europe Adalimumab Biosimilars Production (2018-2029)
1.3.6 China Adalimumab Biosimilars Production (2018-2029)
1.3.7 Japan Adalimumab Biosimilars Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Adalimumab Biosimilars Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Adalimumab Biosimilars Major Market Trends
2 DEMAND SUMMARY
2.1 World Adalimumab Biosimilars Demand (2018-2029)
2.2 World Adalimumab Biosimilars Consumption by Region
2.2.1 World Adalimumab Biosimilars Consumption by Region (2018-2023)
2.2.2 World Adalimumab Biosimilars Consumption Forecast by Region (2024-2029)
2.3 United States Adalimumab Biosimilars Consumption (2018-2029)
2.4 China Adalimumab Biosimilars Consumption (2018-2029)
2.5 Europe Adalimumab Biosimilars Consumption (2018-2029)
2.6 Japan Adalimumab Biosimilars Consumption (2018-2029)
2.7 South Korea Adalimumab Biosimilars Consumption (2018-2029)
2.8 ASEAN Adalimumab Biosimilars Consumption (2018-2029)
2.9 India Adalimumab Biosimilars Consumption (2018-2029)
3 WORLD ADALIMUMAB BIOSIMILARS MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Adalimumab Biosimilars Production Value by Manufacturer (2018-2023)
3.2 World Adalimumab Biosimilars Production by Manufacturer (2018-2023)
3.3 World Adalimumab Biosimilars Average Price by Manufacturer (2018-2023)
3.4 Adalimumab Biosimilars Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Adalimumab Biosimilars Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Adalimumab Biosimilars in 2022
3.5.3 Global Concentration Ratios (CR8) for Adalimumab Biosimilars in 2022
3.6 Adalimumab Biosimilars Market: Overall Company Footprint Analysis
3.6.1 Adalimumab Biosimilars Market: Region Footprint
3.6.2 Adalimumab Biosimilars Market: Company Product Type Footprint
3.6.3 Adalimumab Biosimilars Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Adalimumab Biosimilars Production Value Comparison
4.1.1 United States VS China: Adalimumab Biosimilars Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Adalimumab Biosimilars Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Adalimumab Biosimilars Production Comparison
4.2.1 United States VS China: Adalimumab Biosimilars Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Adalimumab Biosimilars Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Adalimumab Biosimilars Consumption Comparison
4.3.1 United States VS China: Adalimumab Biosimilars Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Adalimumab Biosimilars Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Adalimumab Biosimilars Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Adalimumab Biosimilars Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Adalimumab Biosimilars Production Value (2018-2023)
4.4.3 United States Based Manufacturers Adalimumab Biosimilars Production (2018-2023)
4.5 China Based Adalimumab Biosimilars Manufacturers and Market Share
4.5.1 China Based Adalimumab Biosimilars Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Adalimumab Biosimilars Production Value (2018-2023)
4.5.3 China Based Manufacturers Adalimumab Biosimilars Production (2018-2023)
4.6 Rest of World Based Adalimumab Biosimilars Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Adalimumab Biosimilars Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Adalimumab Biosimilars Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Adalimumab Biosimilars Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Adalimumab Biosimilars Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 80mg
5.2.2 40mg
5.2.3 20mg
5.3 Market Segment by Type
5.3.1 World Adalimumab Biosimilars Production by Type (2018-2029)
5.3.2 World Adalimumab Biosimilars Production Value by Type (2018-2029)
5.3.3 World Adalimumab Biosimilars Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Adalimumab Biosimilars Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Adult
6.2.2 Child
6.3 Market Segment by Application
6.3.1 World Adalimumab Biosimilars Production by Application (2018-2029)
6.3.2 World Adalimumab Biosimilars Production Value by Application (2018-2029)
6.3.3 World Adalimumab Biosimilars Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Biotech
7.1.1 Biotech Details
7.1.2 Biotech Major Business
7.1.3 Biotech Adalimumab Biosimilars Product and Services
7.1.4 Biotech Adalimumab Biosimilars Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Biotech Recent Developments/Updates
7.1.6 Biotech Competitive Strengths & Weaknesses
7.2 Hisun Pharmaceutical
7.2.1 Hisun Pharmaceutical Details
7.2.2 Hisun Pharmaceutical Major Business
7.2.3 Hisun Pharmaceutical Adalimumab Biosimilars Product and Services
7.2.4 Hisun Pharmaceutical Adalimumab Biosimilars Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Hisun Pharmaceutical Recent Developments/Updates
7.2.6 Hisun Pharmaceutical Competitive Strengths & Weaknesses
7.3 Innovent Biologics
7.3.1 Innovent Biologics Details
7.3.2 Innovent Biologics Major Business
7.3.3 Innovent Biologics Adalimumab Biosimilars Product and Services
7.3.4 Innovent Biologics Adalimumab Biosimilars Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Innovent Biologics Recent Developments/Updates
7.3.6 Innovent Biologics Competitive Strengths & Weaknesses
7.4 Fuhong Hanlin
7.4.1 Fuhong Hanlin Details
7.4.2 Fuhong Hanlin Major Business
7.4.3 Fuhong Hanlin Adalimumab Biosimilars Product and Services
7.4.4 Fuhong Hanlin Adalimumab Biosimilars Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Fuhong Hanlin Recent Developments/Updates
7.4.6 Fuhong Hanlin Competitive Strengths & Weaknesses
7.5 China Biopharmaceuticals
7.5.1 China Biopharmaceuticals Details
7.5.2 China Biopharmaceuticals Major Business
7.5.3 China Biopharmaceuticals Adalimumab Biosimilars Product and Services
7.5.4 China Biopharmaceuticals Adalimumab Biosimilars Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 China Biopharmaceuticals Recent Developments/Updates
7.5.6 China Biopharmaceuticals Competitive Strengths & Weaknesses
7.6 Chia Tai Tianqing Pharmaceutical Group
7.6.1 Chia Tai Tianqing Pharmaceutical Group Details
7.6.2 Chia Tai Tianqing Pharmaceutical Group Major Business
7.6.3 Chia Tai Tianqing Pharmaceutical Group Adalimumab Biosimilars Product and Services
7.6.4 Chia Tai Tianqing Pharmaceutical Group Adalimumab Biosimilars Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Chia Tai Tianqing Pharmaceutical Group Recent Developments/Updates
7.6.6 Chia Tai Tianqing Pharmaceutical Group Competitive Strengths & Weaknesses
7.7 China Cell Engineering
7.7.1 China Cell Engineering Details
7.7.2 China Cell Engineering Major Business
7.7.3 China Cell Engineering Adalimumab Biosimilars Product and Services
7.7.4 China Cell Engineering Adalimumab Biosimilars Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 China Cell Engineering Recent Developments/Updates
7.7.6 China Cell Engineering Competitive Strengths & Weaknesses
7.8 Suzhou Zhonghe Biomedical Technology
7.8.1 Suzhou Zhonghe Biomedical Technology Details
7.8.2 Suzhou Zhonghe Biomedical Technology Major Business
7.8.3 Suzhou Zhonghe Biomedical Technology Adalimumab Biosimilars Product and Services
7.8.4 Suzhou Zhonghe Biomedical Technology Adalimumab Biosimilars Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Suzhou Zhonghe Biomedical Technology Recent Developments/Updates
7.8.6 Suzhou Zhonghe Biomedical Technology Competitive Strengths & Weaknesses
7.9 Amgen
7.9.1 Amgen Details
7.9.2 Amgen Major Business
7.9.3 Amgen Adalimumab Biosimilars Product and Services
7.9.4 Amgen Adalimumab Biosimilars Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Amgen Recent Developments/Updates
7.9.6 Amgen Competitive Strengths & Weaknesses
7.10 Sandoz
7.10.1 Sandoz Details
7.10.2 Sandoz Major Business
7.10.3 Sandoz Adalimumab Biosimilars Product and Services
7.10.4 Sandoz Adalimumab Biosimilars Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Sandoz Recent Developments/Updates
7.10.6 Sandoz Competitive Strengths & Weaknesses
7.11 Boehringer Ingelheim
7.11.1 Boehringer Ingelheim Details
7.11.2 Boehringer Ingelheim Major Business
7.11.3 Boehringer Ingelheim Adalimumab Biosimilars Product and Services
7.11.4 Boehringer Ingelheim Adalimumab Biosimilars Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 Boehringer Ingelheim Recent Developments/Updates
7.11.6 Boehringer Ingelheim Competitive Strengths & Weaknesses
7.12 Mylan
7.12.1 Mylan Details
7.12.2 Mylan Major Business
7.12.3 Mylan Adalimumab Biosimilars Product and Services
7.12.4 Mylan Adalimumab Biosimilars Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 Mylan Recent Developments/Updates
7.12.6 Mylan Competitive Strengths & Weaknesses
7.13 Biogen
7.13.1 Biogen Details
7.13.2 Biogen Major Business
7.13.3 Biogen Adalimumab Biosimilars Product and Services
7.13.4 Biogen Adalimumab Biosimilars Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.13.5 Biogen Recent Developments/Updates
7.13.6 Biogen Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Adalimumab Biosimilars Industry Chain
8.2 Adalimumab Biosimilars Upstream Analysis
8.2.1 Adalimumab Biosimilars Core Raw Materials
8.2.2 Main Manufacturers of Adalimumab Biosimilars Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Adalimumab Biosimilars Production Mode
8.6 Adalimumab Biosimilars Procurement Model
8.7 Adalimumab Biosimilars Industry Sales Model and Sales Channels
8.7.1 Adalimumab Biosimilars Sales Model
8.7.2 Adalimumab Biosimilars Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Adalimumab Biosimilars Introduction
1.2 World Adalimumab Biosimilars Supply & Forecast
1.2.1 World Adalimumab Biosimilars Production Value (2018 & 2022 & 2029)
1.2.2 World Adalimumab Biosimilars Production (2018-2029)
1.2.3 World Adalimumab Biosimilars Pricing Trends (2018-2029)
1.3 World Adalimumab Biosimilars Production by Region (Based on Production Site)
1.3.1 World Adalimumab Biosimilars Production Value by Region (2018-2029)
1.3.2 World Adalimumab Biosimilars Production by Region (2018-2029)
1.3.3 World Adalimumab Biosimilars Average Price by Region (2018-2029)
1.3.4 North America Adalimumab Biosimilars Production (2018-2029)
1.3.5 Europe Adalimumab Biosimilars Production (2018-2029)
1.3.6 China Adalimumab Biosimilars Production (2018-2029)
1.3.7 Japan Adalimumab Biosimilars Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Adalimumab Biosimilars Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Adalimumab Biosimilars Major Market Trends
2 DEMAND SUMMARY
2.1 World Adalimumab Biosimilars Demand (2018-2029)
2.2 World Adalimumab Biosimilars Consumption by Region
2.2.1 World Adalimumab Biosimilars Consumption by Region (2018-2023)
2.2.2 World Adalimumab Biosimilars Consumption Forecast by Region (2024-2029)
2.3 United States Adalimumab Biosimilars Consumption (2018-2029)
2.4 China Adalimumab Biosimilars Consumption (2018-2029)
2.5 Europe Adalimumab Biosimilars Consumption (2018-2029)
2.6 Japan Adalimumab Biosimilars Consumption (2018-2029)
2.7 South Korea Adalimumab Biosimilars Consumption (2018-2029)
2.8 ASEAN Adalimumab Biosimilars Consumption (2018-2029)
2.9 India Adalimumab Biosimilars Consumption (2018-2029)
3 WORLD ADALIMUMAB BIOSIMILARS MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Adalimumab Biosimilars Production Value by Manufacturer (2018-2023)
3.2 World Adalimumab Biosimilars Production by Manufacturer (2018-2023)
3.3 World Adalimumab Biosimilars Average Price by Manufacturer (2018-2023)
3.4 Adalimumab Biosimilars Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Adalimumab Biosimilars Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Adalimumab Biosimilars in 2022
3.5.3 Global Concentration Ratios (CR8) for Adalimumab Biosimilars in 2022
3.6 Adalimumab Biosimilars Market: Overall Company Footprint Analysis
3.6.1 Adalimumab Biosimilars Market: Region Footprint
3.6.2 Adalimumab Biosimilars Market: Company Product Type Footprint
3.6.3 Adalimumab Biosimilars Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Adalimumab Biosimilars Production Value Comparison
4.1.1 United States VS China: Adalimumab Biosimilars Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Adalimumab Biosimilars Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Adalimumab Biosimilars Production Comparison
4.2.1 United States VS China: Adalimumab Biosimilars Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Adalimumab Biosimilars Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Adalimumab Biosimilars Consumption Comparison
4.3.1 United States VS China: Adalimumab Biosimilars Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Adalimumab Biosimilars Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Adalimumab Biosimilars Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Adalimumab Biosimilars Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Adalimumab Biosimilars Production Value (2018-2023)
4.4.3 United States Based Manufacturers Adalimumab Biosimilars Production (2018-2023)
4.5 China Based Adalimumab Biosimilars Manufacturers and Market Share
4.5.1 China Based Adalimumab Biosimilars Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Adalimumab Biosimilars Production Value (2018-2023)
4.5.3 China Based Manufacturers Adalimumab Biosimilars Production (2018-2023)
4.6 Rest of World Based Adalimumab Biosimilars Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Adalimumab Biosimilars Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Adalimumab Biosimilars Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Adalimumab Biosimilars Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Adalimumab Biosimilars Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 80mg
5.2.2 40mg
5.2.3 20mg
5.3 Market Segment by Type
5.3.1 World Adalimumab Biosimilars Production by Type (2018-2029)
5.3.2 World Adalimumab Biosimilars Production Value by Type (2018-2029)
5.3.3 World Adalimumab Biosimilars Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Adalimumab Biosimilars Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Adult
6.2.2 Child
6.3 Market Segment by Application
6.3.1 World Adalimumab Biosimilars Production by Application (2018-2029)
6.3.2 World Adalimumab Biosimilars Production Value by Application (2018-2029)
6.3.3 World Adalimumab Biosimilars Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Biotech
7.1.1 Biotech Details
7.1.2 Biotech Major Business
7.1.3 Biotech Adalimumab Biosimilars Product and Services
7.1.4 Biotech Adalimumab Biosimilars Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Biotech Recent Developments/Updates
7.1.6 Biotech Competitive Strengths & Weaknesses
7.2 Hisun Pharmaceutical
7.2.1 Hisun Pharmaceutical Details
7.2.2 Hisun Pharmaceutical Major Business
7.2.3 Hisun Pharmaceutical Adalimumab Biosimilars Product and Services
7.2.4 Hisun Pharmaceutical Adalimumab Biosimilars Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Hisun Pharmaceutical Recent Developments/Updates
7.2.6 Hisun Pharmaceutical Competitive Strengths & Weaknesses
7.3 Innovent Biologics
7.3.1 Innovent Biologics Details
7.3.2 Innovent Biologics Major Business
7.3.3 Innovent Biologics Adalimumab Biosimilars Product and Services
7.3.4 Innovent Biologics Adalimumab Biosimilars Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Innovent Biologics Recent Developments/Updates
7.3.6 Innovent Biologics Competitive Strengths & Weaknesses
7.4 Fuhong Hanlin
7.4.1 Fuhong Hanlin Details
7.4.2 Fuhong Hanlin Major Business
7.4.3 Fuhong Hanlin Adalimumab Biosimilars Product and Services
7.4.4 Fuhong Hanlin Adalimumab Biosimilars Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Fuhong Hanlin Recent Developments/Updates
7.4.6 Fuhong Hanlin Competitive Strengths & Weaknesses
7.5 China Biopharmaceuticals
7.5.1 China Biopharmaceuticals Details
7.5.2 China Biopharmaceuticals Major Business
7.5.3 China Biopharmaceuticals Adalimumab Biosimilars Product and Services
7.5.4 China Biopharmaceuticals Adalimumab Biosimilars Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 China Biopharmaceuticals Recent Developments/Updates
7.5.6 China Biopharmaceuticals Competitive Strengths & Weaknesses
7.6 Chia Tai Tianqing Pharmaceutical Group
7.6.1 Chia Tai Tianqing Pharmaceutical Group Details
7.6.2 Chia Tai Tianqing Pharmaceutical Group Major Business
7.6.3 Chia Tai Tianqing Pharmaceutical Group Adalimumab Biosimilars Product and Services
7.6.4 Chia Tai Tianqing Pharmaceutical Group Adalimumab Biosimilars Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Chia Tai Tianqing Pharmaceutical Group Recent Developments/Updates
7.6.6 Chia Tai Tianqing Pharmaceutical Group Competitive Strengths & Weaknesses
7.7 China Cell Engineering
7.7.1 China Cell Engineering Details
7.7.2 China Cell Engineering Major Business
7.7.3 China Cell Engineering Adalimumab Biosimilars Product and Services
7.7.4 China Cell Engineering Adalimumab Biosimilars Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 China Cell Engineering Recent Developments/Updates
7.7.6 China Cell Engineering Competitive Strengths & Weaknesses
7.8 Suzhou Zhonghe Biomedical Technology
7.8.1 Suzhou Zhonghe Biomedical Technology Details
7.8.2 Suzhou Zhonghe Biomedical Technology Major Business
7.8.3 Suzhou Zhonghe Biomedical Technology Adalimumab Biosimilars Product and Services
7.8.4 Suzhou Zhonghe Biomedical Technology Adalimumab Biosimilars Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Suzhou Zhonghe Biomedical Technology Recent Developments/Updates
7.8.6 Suzhou Zhonghe Biomedical Technology Competitive Strengths & Weaknesses
7.9 Amgen
7.9.1 Amgen Details
7.9.2 Amgen Major Business
7.9.3 Amgen Adalimumab Biosimilars Product and Services
7.9.4 Amgen Adalimumab Biosimilars Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Amgen Recent Developments/Updates
7.9.6 Amgen Competitive Strengths & Weaknesses
7.10 Sandoz
7.10.1 Sandoz Details
7.10.2 Sandoz Major Business
7.10.3 Sandoz Adalimumab Biosimilars Product and Services
7.10.4 Sandoz Adalimumab Biosimilars Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Sandoz Recent Developments/Updates
7.10.6 Sandoz Competitive Strengths & Weaknesses
7.11 Boehringer Ingelheim
7.11.1 Boehringer Ingelheim Details
7.11.2 Boehringer Ingelheim Major Business
7.11.3 Boehringer Ingelheim Adalimumab Biosimilars Product and Services
7.11.4 Boehringer Ingelheim Adalimumab Biosimilars Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 Boehringer Ingelheim Recent Developments/Updates
7.11.6 Boehringer Ingelheim Competitive Strengths & Weaknesses
7.12 Mylan
7.12.1 Mylan Details
7.12.2 Mylan Major Business
7.12.3 Mylan Adalimumab Biosimilars Product and Services
7.12.4 Mylan Adalimumab Biosimilars Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 Mylan Recent Developments/Updates
7.12.6 Mylan Competitive Strengths & Weaknesses
7.13 Biogen
7.13.1 Biogen Details
7.13.2 Biogen Major Business
7.13.3 Biogen Adalimumab Biosimilars Product and Services
7.13.4 Biogen Adalimumab Biosimilars Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.13.5 Biogen Recent Developments/Updates
7.13.6 Biogen Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Adalimumab Biosimilars Industry Chain
8.2 Adalimumab Biosimilars Upstream Analysis
8.2.1 Adalimumab Biosimilars Core Raw Materials
8.2.2 Main Manufacturers of Adalimumab Biosimilars Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Adalimumab Biosimilars Production Mode
8.6 Adalimumab Biosimilars Procurement Model
8.7 Adalimumab Biosimilars Industry Sales Model and Sales Channels
8.7.1 Adalimumab Biosimilars Sales Model
8.7.2 Adalimumab Biosimilars Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Adalimumab Biosimilars Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Adalimumab Biosimilars Production Value by Region (2018-2023) & (USD Million)
Table 3. World Adalimumab Biosimilars Production Value by Region (2024-2029) & (USD Million)
Table 4. World Adalimumab Biosimilars Production Value Market Share by Region (2018-2023)
Table 5. World Adalimumab Biosimilars Production Value Market Share by Region (2024-2029)
Table 6. World Adalimumab Biosimilars Production by Region (2018-2023) & (K Units)
Table 7. World Adalimumab Biosimilars Production by Region (2024-2029) & (K Units)
Table 8. World Adalimumab Biosimilars Production Market Share by Region (2018-2023)
Table 9. World Adalimumab Biosimilars Production Market Share by Region (2024-2029)
Table 10. World Adalimumab Biosimilars Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Adalimumab Biosimilars Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Adalimumab Biosimilars Major Market Trends
Table 13. World Adalimumab Biosimilars Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Adalimumab Biosimilars Consumption by Region (2018-2023) & (K Units)
Table 15. World Adalimumab Biosimilars Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Adalimumab Biosimilars Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Adalimumab Biosimilars Producers in 2022
Table 18. World Adalimumab Biosimilars Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Adalimumab Biosimilars Producers in 2022
Table 20. World Adalimumab Biosimilars Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Adalimumab Biosimilars Company Evaluation Quadrant
Table 22. World Adalimumab Biosimilars Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Adalimumab Biosimilars Production Site of Key Manufacturer
Table 24. Adalimumab Biosimilars Market: Company Product Type Footprint
Table 25. Adalimumab Biosimilars Market: Company Product Application Footprint
Table 26. Adalimumab Biosimilars Competitive Factors
Table 27. Adalimumab Biosimilars New Entrant and Capacity Expansion Plans
Table 28. Adalimumab Biosimilars Mergers & Acquisitions Activity
Table 29. United States VS China Adalimumab Biosimilars Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Adalimumab Biosimilars Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Adalimumab Biosimilars Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Adalimumab Biosimilars Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Adalimumab Biosimilars Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Adalimumab Biosimilars Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Adalimumab Biosimilars Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Adalimumab Biosimilars Production Market Share (2018-2023)
Table 37. China Based Adalimumab Biosimilars Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Adalimumab Biosimilars Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Adalimumab Biosimilars Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Adalimumab Biosimilars Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Adalimumab Biosimilars Production Market Share (2018-2023)
Table 42. Rest of World Based Adalimumab Biosimilars Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Adalimumab Biosimilars Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Adalimumab Biosimilars Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Adalimumab Biosimilars Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Adalimumab Biosimilars Production Market Share (2018-2023)
Table 47. World Adalimumab Biosimilars Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Adalimumab Biosimilars Production by Type (2018-2023) & (K Units)
Table 49. World Adalimumab Biosimilars Production by Type (2024-2029) & (K Units)
Table 50. World Adalimumab Biosimilars Production Value by Type (2018-2023) & (USD Million)
Table 51. World Adalimumab Biosimilars Production Value by Type (2024-2029) & (USD Million)
Table 52. World Adalimumab Biosimilars Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Adalimumab Biosimilars Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Adalimumab Biosimilars Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Adalimumab Biosimilars Production by Application (2018-2023) & (K Units)
Table 56. World Adalimumab Biosimilars Production by Application (2024-2029) & (K Units)
Table 57. World Adalimumab Biosimilars Production Value by Application (2018-2023) & (USD Million)
Table 58. World Adalimumab Biosimilars Production Value by Application (2024-2029) & (USD Million)
Table 59. World Adalimumab Biosimilars Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Adalimumab Biosimilars Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Biotech Basic Information, Manufacturing Base and Competitors
Table 62. Biotech Major Business
Table 63. Biotech Adalimumab Biosimilars Product and Services
Table 64. Biotech Adalimumab Biosimilars Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Biotech Recent Developments/Updates
Table 66. Biotech Competitive Strengths & Weaknesses
Table 67. Hisun Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 68. Hisun Pharmaceutical Major Business
Table 69. Hisun Pharmaceutical Adalimumab Biosimilars Product and Services
Table 70. Hisun Pharmaceutical Adalimumab Biosimilars Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Hisun Pharmaceutical Recent Developments/Updates
Table 72. Hisun Pharmaceutical Competitive Strengths & Weaknesses
Table 73. Innovent Biologics Basic Information, Manufacturing Base and Competitors
Table 74. Innovent Biologics Major Business
Table 75. Innovent Biologics Adalimumab Biosimilars Product and Services
Table 76. Innovent Biologics Adalimumab Biosimilars Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Innovent Biologics Recent Developments/Updates
Table 78. Innovent Biologics Competitive Strengths & Weaknesses
Table 79. Fuhong Hanlin Basic Information, Manufacturing Base and Competitors
Table 80. Fuhong Hanlin Major Business
Table 81. Fuhong Hanlin Adalimumab Biosimilars Product and Services
Table 82. Fuhong Hanlin Adalimumab Biosimilars Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Fuhong Hanlin Recent Developments/Updates
Table 84. Fuhong Hanlin Competitive Strengths & Weaknesses
Table 85. China Biopharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 86. China Biopharmaceuticals Major Business
Table 87. China Biopharmaceuticals Adalimumab Biosimilars Product and Services
Table 88. China Biopharmaceuticals Adalimumab Biosimilars Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. China Biopharmaceuticals Recent Developments/Updates
Table 90. China Biopharmaceuticals Competitive Strengths & Weaknesses
Table 91. Chia Tai Tianqing Pharmaceutical Group Basic Information, Manufacturing Base and Competitors
Table 92. Chia Tai Tianqing Pharmaceutical Group Major Business
Table 93. Chia Tai Tianqing Pharmaceutical Group Adalimumab Biosimilars Product and Services
Table 94. Chia Tai Tianqing Pharmaceutical Group Adalimumab Biosimilars Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Chia Tai Tianqing Pharmaceutical Group Recent Developments/Updates
Table 96. Chia Tai Tianqing Pharmaceutical Group Competitive Strengths & Weaknesses
Table 97. China Cell Engineering Basic Information, Manufacturing Base and Competitors
Table 98. China Cell Engineering Major Business
Table 99. China Cell Engineering Adalimumab Biosimilars Product and Services
Table 100. China Cell Engineering Adalimumab Biosimilars Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. China Cell Engineering Recent Developments/Updates
Table 102. China Cell Engineering Competitive Strengths & Weaknesses
Table 103. Suzhou Zhonghe Biomedical Technology Basic Information, Manufacturing Base and Competitors
Table 104. Suzhou Zhonghe Biomedical Technology Major Business
Table 105. Suzhou Zhonghe Biomedical Technology Adalimumab Biosimilars Product and Services
Table 106. Suzhou Zhonghe Biomedical Technology Adalimumab Biosimilars Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Suzhou Zhonghe Biomedical Technology Recent Developments/Updates
Table 108. Suzhou Zhonghe Biomedical Technology Competitive Strengths & Weaknesses
Table 109. Amgen Basic Information, Manufacturing Base and Competitors
Table 110. Amgen Major Business
Table 111. Amgen Adalimumab Biosimilars Product and Services
Table 112. Amgen Adalimumab Biosimilars Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Amgen Recent Developments/Updates
Table 114. Amgen Competitive Strengths & Weaknesses
Table 115. Sandoz Basic Information, Manufacturing Base and Competitors
Table 116. Sandoz Major Business
Table 117. Sandoz Adalimumab Biosimilars Product and Services
Table 118. Sandoz Adalimumab Biosimilars Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Sandoz Recent Developments/Updates
Table 120. Sandoz Competitive Strengths & Weaknesses
Table 121. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 122. Boehringer Ingelheim Major Business
Table 123. Boehringer Ingelheim Adalimumab Biosimilars Product and Services
Table 124. Boehringer Ingelheim Adalimumab Biosimilars Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. Boehringer Ingelheim Recent Developments/Updates
Table 126. Boehringer Ingelheim Competitive Strengths & Weaknesses
Table 127. Mylan Basic Information, Manufacturing Base and Competitors
Table 128. Mylan Major Business
Table 129. Mylan Adalimumab Biosimilars Product and Services
Table 130. Mylan Adalimumab Biosimilars Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. Mylan Recent Developments/Updates
Table 132. Biogen Basic Information, Manufacturing Base and Competitors
Table 133. Biogen Major Business
Table 134. Biogen Adalimumab Biosimilars Product and Services
Table 135. Biogen Adalimumab Biosimilars Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 136. Global Key Players of Adalimumab Biosimilars Upstream (Raw Materials)
Table 137. Adalimumab Biosimilars Typical Customers
Table 138. Adalimumab Biosimilars Typical Distributors
LIST OF FIGURE
Figure 1. Adalimumab Biosimilars Picture
Figure 2. World Adalimumab Biosimilars Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Adalimumab Biosimilars Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Adalimumab Biosimilars Production (2018-2029) & (K Units)
Figure 5. World Adalimumab Biosimilars Average Price (2018-2029) & (US$/Unit)
Figure 6. World Adalimumab Biosimilars Production Value Market Share by Region (2018-2029)
Figure 7. World Adalimumab Biosimilars Production Market Share by Region (2018-2029)
Figure 8. North America Adalimumab Biosimilars Production (2018-2029) & (K Units)
Figure 9. Europe Adalimumab Biosimilars Production (2018-2029) & (K Units)
Figure 10. China Adalimumab Biosimilars Production (2018-2029) & (K Units)
Figure 11. Japan Adalimumab Biosimilars Production (2018-2029) & (K Units)
Figure 12. Adalimumab Biosimilars Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Adalimumab Biosimilars Consumption (2018-2029) & (K Units)
Figure 15. World Adalimumab Biosimilars Consumption Market Share by Region (2018-2029)
Figure 16. United States Adalimumab Biosimilars Consumption (2018-2029) & (K Units)
Figure 17. China Adalimumab Biosimilars Consumption (2018-2029) & (K Units)
Figure 18. Europe Adalimumab Biosimilars Consumption (2018-2029) & (K Units)
Figure 19. Japan Adalimumab Biosimilars Consumption (2018-2029) & (K Units)
Figure 20. South Korea Adalimumab Biosimilars Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Adalimumab Biosimilars Consumption (2018-2029) & (K Units)
Figure 22. India Adalimumab Biosimilars Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Adalimumab Biosimilars by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Adalimumab Biosimilars Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Adalimumab Biosimilars Markets in 2022
Figure 26. United States VS China: Adalimumab Biosimilars Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Adalimumab Biosimilars Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Adalimumab Biosimilars Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Adalimumab Biosimilars Production Market Share 2022
Figure 30. China Based Manufacturers Adalimumab Biosimilars Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Adalimumab Biosimilars Production Market Share 2022
Figure 32. World Adalimumab Biosimilars Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Adalimumab Biosimilars Production Value Market Share by Type in 2022
Figure 34. 80mg
Figure 35. 40mg
Figure 36. 20mg
Figure 37. World Adalimumab Biosimilars Production Market Share by Type (2018-2029)
Figure 38. World Adalimumab Biosimilars Production Value Market Share by Type (2018-2029)
Figure 39. World Adalimumab Biosimilars Average Price by Type (2018-2029) & (US$/Unit)
Figure 40. World Adalimumab Biosimilars Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 41. World Adalimumab Biosimilars Production Value Market Share by Application in 2022
Figure 42. Adult
Figure 43. Child
Figure 44. World Adalimumab Biosimilars Production Market Share by Application (2018-2029)
Figure 45. World Adalimumab Biosimilars Production Value Market Share by Application (2018-2029)
Figure 46. World Adalimumab Biosimilars Average Price by Application (2018-2029) & (US$/Unit)
Figure 47. Adalimumab Biosimilars Industry Chain
Figure 48. Adalimumab Biosimilars Procurement Model
Figure 49. Adalimumab Biosimilars Sales Model
Figure 50. Adalimumab Biosimilars Sales Channels, Direct Sales, and Distribution
Figure 51. Methodology
Figure 52. Research Process and Data Source
Table 1. World Adalimumab Biosimilars Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Adalimumab Biosimilars Production Value by Region (2018-2023) & (USD Million)
Table 3. World Adalimumab Biosimilars Production Value by Region (2024-2029) & (USD Million)
Table 4. World Adalimumab Biosimilars Production Value Market Share by Region (2018-2023)
Table 5. World Adalimumab Biosimilars Production Value Market Share by Region (2024-2029)
Table 6. World Adalimumab Biosimilars Production by Region (2018-2023) & (K Units)
Table 7. World Adalimumab Biosimilars Production by Region (2024-2029) & (K Units)
Table 8. World Adalimumab Biosimilars Production Market Share by Region (2018-2023)
Table 9. World Adalimumab Biosimilars Production Market Share by Region (2024-2029)
Table 10. World Adalimumab Biosimilars Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Adalimumab Biosimilars Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Adalimumab Biosimilars Major Market Trends
Table 13. World Adalimumab Biosimilars Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Adalimumab Biosimilars Consumption by Region (2018-2023) & (K Units)
Table 15. World Adalimumab Biosimilars Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Adalimumab Biosimilars Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Adalimumab Biosimilars Producers in 2022
Table 18. World Adalimumab Biosimilars Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Adalimumab Biosimilars Producers in 2022
Table 20. World Adalimumab Biosimilars Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Adalimumab Biosimilars Company Evaluation Quadrant
Table 22. World Adalimumab Biosimilars Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Adalimumab Biosimilars Production Site of Key Manufacturer
Table 24. Adalimumab Biosimilars Market: Company Product Type Footprint
Table 25. Adalimumab Biosimilars Market: Company Product Application Footprint
Table 26. Adalimumab Biosimilars Competitive Factors
Table 27. Adalimumab Biosimilars New Entrant and Capacity Expansion Plans
Table 28. Adalimumab Biosimilars Mergers & Acquisitions Activity
Table 29. United States VS China Adalimumab Biosimilars Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Adalimumab Biosimilars Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Adalimumab Biosimilars Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Adalimumab Biosimilars Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Adalimumab Biosimilars Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Adalimumab Biosimilars Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Adalimumab Biosimilars Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Adalimumab Biosimilars Production Market Share (2018-2023)
Table 37. China Based Adalimumab Biosimilars Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Adalimumab Biosimilars Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Adalimumab Biosimilars Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Adalimumab Biosimilars Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Adalimumab Biosimilars Production Market Share (2018-2023)
Table 42. Rest of World Based Adalimumab Biosimilars Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Adalimumab Biosimilars Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Adalimumab Biosimilars Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Adalimumab Biosimilars Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Adalimumab Biosimilars Production Market Share (2018-2023)
Table 47. World Adalimumab Biosimilars Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Adalimumab Biosimilars Production by Type (2018-2023) & (K Units)
Table 49. World Adalimumab Biosimilars Production by Type (2024-2029) & (K Units)
Table 50. World Adalimumab Biosimilars Production Value by Type (2018-2023) & (USD Million)
Table 51. World Adalimumab Biosimilars Production Value by Type (2024-2029) & (USD Million)
Table 52. World Adalimumab Biosimilars Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Adalimumab Biosimilars Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Adalimumab Biosimilars Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Adalimumab Biosimilars Production by Application (2018-2023) & (K Units)
Table 56. World Adalimumab Biosimilars Production by Application (2024-2029) & (K Units)
Table 57. World Adalimumab Biosimilars Production Value by Application (2018-2023) & (USD Million)
Table 58. World Adalimumab Biosimilars Production Value by Application (2024-2029) & (USD Million)
Table 59. World Adalimumab Biosimilars Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Adalimumab Biosimilars Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Biotech Basic Information, Manufacturing Base and Competitors
Table 62. Biotech Major Business
Table 63. Biotech Adalimumab Biosimilars Product and Services
Table 64. Biotech Adalimumab Biosimilars Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Biotech Recent Developments/Updates
Table 66. Biotech Competitive Strengths & Weaknesses
Table 67. Hisun Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 68. Hisun Pharmaceutical Major Business
Table 69. Hisun Pharmaceutical Adalimumab Biosimilars Product and Services
Table 70. Hisun Pharmaceutical Adalimumab Biosimilars Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Hisun Pharmaceutical Recent Developments/Updates
Table 72. Hisun Pharmaceutical Competitive Strengths & Weaknesses
Table 73. Innovent Biologics Basic Information, Manufacturing Base and Competitors
Table 74. Innovent Biologics Major Business
Table 75. Innovent Biologics Adalimumab Biosimilars Product and Services
Table 76. Innovent Biologics Adalimumab Biosimilars Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Innovent Biologics Recent Developments/Updates
Table 78. Innovent Biologics Competitive Strengths & Weaknesses
Table 79. Fuhong Hanlin Basic Information, Manufacturing Base and Competitors
Table 80. Fuhong Hanlin Major Business
Table 81. Fuhong Hanlin Adalimumab Biosimilars Product and Services
Table 82. Fuhong Hanlin Adalimumab Biosimilars Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Fuhong Hanlin Recent Developments/Updates
Table 84. Fuhong Hanlin Competitive Strengths & Weaknesses
Table 85. China Biopharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 86. China Biopharmaceuticals Major Business
Table 87. China Biopharmaceuticals Adalimumab Biosimilars Product and Services
Table 88. China Biopharmaceuticals Adalimumab Biosimilars Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. China Biopharmaceuticals Recent Developments/Updates
Table 90. China Biopharmaceuticals Competitive Strengths & Weaknesses
Table 91. Chia Tai Tianqing Pharmaceutical Group Basic Information, Manufacturing Base and Competitors
Table 92. Chia Tai Tianqing Pharmaceutical Group Major Business
Table 93. Chia Tai Tianqing Pharmaceutical Group Adalimumab Biosimilars Product and Services
Table 94. Chia Tai Tianqing Pharmaceutical Group Adalimumab Biosimilars Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Chia Tai Tianqing Pharmaceutical Group Recent Developments/Updates
Table 96. Chia Tai Tianqing Pharmaceutical Group Competitive Strengths & Weaknesses
Table 97. China Cell Engineering Basic Information, Manufacturing Base and Competitors
Table 98. China Cell Engineering Major Business
Table 99. China Cell Engineering Adalimumab Biosimilars Product and Services
Table 100. China Cell Engineering Adalimumab Biosimilars Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. China Cell Engineering Recent Developments/Updates
Table 102. China Cell Engineering Competitive Strengths & Weaknesses
Table 103. Suzhou Zhonghe Biomedical Technology Basic Information, Manufacturing Base and Competitors
Table 104. Suzhou Zhonghe Biomedical Technology Major Business
Table 105. Suzhou Zhonghe Biomedical Technology Adalimumab Biosimilars Product and Services
Table 106. Suzhou Zhonghe Biomedical Technology Adalimumab Biosimilars Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Suzhou Zhonghe Biomedical Technology Recent Developments/Updates
Table 108. Suzhou Zhonghe Biomedical Technology Competitive Strengths & Weaknesses
Table 109. Amgen Basic Information, Manufacturing Base and Competitors
Table 110. Amgen Major Business
Table 111. Amgen Adalimumab Biosimilars Product and Services
Table 112. Amgen Adalimumab Biosimilars Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Amgen Recent Developments/Updates
Table 114. Amgen Competitive Strengths & Weaknesses
Table 115. Sandoz Basic Information, Manufacturing Base and Competitors
Table 116. Sandoz Major Business
Table 117. Sandoz Adalimumab Biosimilars Product and Services
Table 118. Sandoz Adalimumab Biosimilars Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Sandoz Recent Developments/Updates
Table 120. Sandoz Competitive Strengths & Weaknesses
Table 121. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 122. Boehringer Ingelheim Major Business
Table 123. Boehringer Ingelheim Adalimumab Biosimilars Product and Services
Table 124. Boehringer Ingelheim Adalimumab Biosimilars Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. Boehringer Ingelheim Recent Developments/Updates
Table 126. Boehringer Ingelheim Competitive Strengths & Weaknesses
Table 127. Mylan Basic Information, Manufacturing Base and Competitors
Table 128. Mylan Major Business
Table 129. Mylan Adalimumab Biosimilars Product and Services
Table 130. Mylan Adalimumab Biosimilars Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. Mylan Recent Developments/Updates
Table 132. Biogen Basic Information, Manufacturing Base and Competitors
Table 133. Biogen Major Business
Table 134. Biogen Adalimumab Biosimilars Product and Services
Table 135. Biogen Adalimumab Biosimilars Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 136. Global Key Players of Adalimumab Biosimilars Upstream (Raw Materials)
Table 137. Adalimumab Biosimilars Typical Customers
Table 138. Adalimumab Biosimilars Typical Distributors
LIST OF FIGURE
Figure 1. Adalimumab Biosimilars Picture
Figure 2. World Adalimumab Biosimilars Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Adalimumab Biosimilars Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Adalimumab Biosimilars Production (2018-2029) & (K Units)
Figure 5. World Adalimumab Biosimilars Average Price (2018-2029) & (US$/Unit)
Figure 6. World Adalimumab Biosimilars Production Value Market Share by Region (2018-2029)
Figure 7. World Adalimumab Biosimilars Production Market Share by Region (2018-2029)
Figure 8. North America Adalimumab Biosimilars Production (2018-2029) & (K Units)
Figure 9. Europe Adalimumab Biosimilars Production (2018-2029) & (K Units)
Figure 10. China Adalimumab Biosimilars Production (2018-2029) & (K Units)
Figure 11. Japan Adalimumab Biosimilars Production (2018-2029) & (K Units)
Figure 12. Adalimumab Biosimilars Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Adalimumab Biosimilars Consumption (2018-2029) & (K Units)
Figure 15. World Adalimumab Biosimilars Consumption Market Share by Region (2018-2029)
Figure 16. United States Adalimumab Biosimilars Consumption (2018-2029) & (K Units)
Figure 17. China Adalimumab Biosimilars Consumption (2018-2029) & (K Units)
Figure 18. Europe Adalimumab Biosimilars Consumption (2018-2029) & (K Units)
Figure 19. Japan Adalimumab Biosimilars Consumption (2018-2029) & (K Units)
Figure 20. South Korea Adalimumab Biosimilars Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Adalimumab Biosimilars Consumption (2018-2029) & (K Units)
Figure 22. India Adalimumab Biosimilars Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Adalimumab Biosimilars by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Adalimumab Biosimilars Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Adalimumab Biosimilars Markets in 2022
Figure 26. United States VS China: Adalimumab Biosimilars Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Adalimumab Biosimilars Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Adalimumab Biosimilars Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Adalimumab Biosimilars Production Market Share 2022
Figure 30. China Based Manufacturers Adalimumab Biosimilars Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Adalimumab Biosimilars Production Market Share 2022
Figure 32. World Adalimumab Biosimilars Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Adalimumab Biosimilars Production Value Market Share by Type in 2022
Figure 34. 80mg
Figure 35. 40mg
Figure 36. 20mg
Figure 37. World Adalimumab Biosimilars Production Market Share by Type (2018-2029)
Figure 38. World Adalimumab Biosimilars Production Value Market Share by Type (2018-2029)
Figure 39. World Adalimumab Biosimilars Average Price by Type (2018-2029) & (US$/Unit)
Figure 40. World Adalimumab Biosimilars Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 41. World Adalimumab Biosimilars Production Value Market Share by Application in 2022
Figure 42. Adult
Figure 43. Child
Figure 44. World Adalimumab Biosimilars Production Market Share by Application (2018-2029)
Figure 45. World Adalimumab Biosimilars Production Value Market Share by Application (2018-2029)
Figure 46. World Adalimumab Biosimilars Average Price by Application (2018-2029) & (US$/Unit)
Figure 47. Adalimumab Biosimilars Industry Chain
Figure 48. Adalimumab Biosimilars Procurement Model
Figure 49. Adalimumab Biosimilars Sales Model
Figure 50. Adalimumab Biosimilars Sales Channels, Direct Sales, and Distribution
Figure 51. Methodology
Figure 52. Research Process and Data Source
